Mark Reddington, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11560 Chapman Hwy, Suite 1, Seymour, TN 37865 Phone: 865-577-1914 Fax: 865-577-1714 |
News Archive
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
ABM, a leading provider of facility solutions, today announced the launch of its ABM Healthcare Support Services business, which combines the strengths of HHA Services, Healthcare Parking Systems of America and ABM Health.
Chance makes it impossible to assess reliably whether hospitals are meeting government targets to reduce MRSA infections, argues a statistics expert in this week's British Medical Journal.
The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universitaet Muenchen), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer.
› Verified 4 days ago